Health Care and Research

Slides:

Advertisements

Similar presentations

Inflammatory Bowel Disease: Overview

Advertisements

Is there a link between inflammatory bowel disease and the metabolic syndrome? Hester Franks Academic F2 Supervisors Professors Hawkey and Macdonald.

Welcome to the new acute and community County Durham and Darlington NHS Foundation Trust Clinical strategy FT member events April 2011.

Inpatient care and inpatient experience of young people with ulcerative colitis in the UK [Presenter / title] [Date of presentation]

Dalia Munoz.  Its an inflammatory bowel disease (IBD) that causes a long- lasting inflammation in your digestive tract.

Crohn’s disease - A Review of Symptoms and Treatment

Component 1: Introduction to Health Care and Public Health in the U.S. 1.5: Unit 5: Financing Health Care (Part 2) 1.5d: Controlling Medical Expenses.

Why pain should be on everyone’s agenda Dr Beverly Collett Consultant in Pain Medicine University Hospitals of Leicester Board Member Faculty of Pain Medicine.

25 January 2013 Dr Ian Arnott UK Inflammatory Bowel Disease (IBD) audit Audit of inpatients with ulcerative colitis 1st January 2013 – 31st December 2013.

1 European Health Forum Gastein Lunch Workshop 1 6 October 2005 What do the patients expect from health professionals? Rod Mitchell, Chairman European.

Workshop The science and methodologies behind HTA, diversity and commonality across the EU Achieving more patient centred HTA in different countries.

Current challenges for health systems Increasing elderly population –Relative decrease in resources (fewer taxpayers), chronic patients Financial sustainability.

Moving forward in partnership: Developing a roadmap to promulgate and implement the European Cancer Patient’s Bill of Rights Mark Lawler ECC Project Lead.

Maryam Treifi Dr. Mircea Muresan Faculty of Medicine, UMPh Targu Mureș Department of Surgery Targu Mures County Hospital.

THE OUTPATIENT BURDEN OF IBD: A 10 YEAR REVIEW M. W. Johnson, K. Lithgo, T. Prouse, T. Price Gastroenterology Department, Luton & Dunstable University.

CLINICAL AND ENDOSCOPIC CORRELATION OF INFLAMMATORY BOWEL DISEASE Coordinator: Prof. Univ. Dr. Simona Băţagă Students: Andra Oltean Stoica Ioan Adrian.

(Date of presentation) (Name of presenter) UK IBD audit Biological therapies audit 2014 Comparison of (Your site name) results against the national results.

EARIP Stakeholder Workshop Models and healthcare systems: transferability of best practice across Europe Dr. Aurélien PEREZ European Commission Health.

EDIFY Healthcare Reform Update. The Rising Cost of Health Care “The high cost of health care has created a real burden for the great financial middle.

Baumgart, D C The Diagnosis and Treatment of Crohn's Disease and Ulcerative Colitis Dtsch Arztebl Int 2009; 106(8): ; DOI: /arztebl

CHAPTER 19 Inflammatory Bowel Disease Source: Burden of digestive diseases in the United States, NIH Publication No

EUNetPaS is a project supported by a grant from the EAHC. The sole responsibility for the content of this presentation lies with the author(s). The EAHC.

Welcome to Newly Diagnosed Night!. Overview Explanation of IBD Review of GI System Differences between Crohn’s and Colitis Who gets IBD.

ELEVENTH SCIENTIFIC & ANNUAL MEETING Milan 28 – 30 SEPTEMBER 2016 VISIT FOR FURTHER INFORMATION.

(Date of presentation) (Name of presenter) UK IBD audit Biological therapies audit 2015 Comparison of (Your site name) results against the national results.

Page  2 Accutane, a medication used to treat acne, has recently been linked to dangerous health conditions such as inflammatory bowel disease (IBD).

HCS 440 Week 1 DQ 2 What is a demand curve? Provide an example of a demand curve in health care. How could this example affect the economics of health.

HCS 440 Week 3 Learning Team Health Care Reform Project Part II To purchase this material click below link

A personal journey through IBD

Progress and future developments

INTERNATIONAL SYMPOSIUM ON FUNDED BY PATIENTS' ORGANISATIONS

Fabio V. Teixeira, MD, MSc, PhD

INTERNATIONAL SYMPOSIUM ON FUNDED BY PATIENTS' ORGANISATIONS

Opiate use in patients with inflammatory bowel disease

High and increasing prevalence of inflammatory bowel disease in Finland with a clear North–South difference Airi Jussila, Lauri J. Virta, Veikko Salomaa,

Work disability in inflammatory bowel disease

PATIENT ACTIVATION IN INFLAMMATORY BOWEL DISEASE PATIENTS

WHO ARE WE The IMAGINE Network is investigating the interactions between inflammation, microbiome, diet and mental health in patients with inflammatory.

Ulcerative Colitis (UC)-Associated Colorectal Cancer (CRC) Patients Who Receives Colorectal Surgery More Likely Receive Blood Transfusion Than Crohn’s.

National audit of paediatric IBD service provision

WHO ARE WE The IMAGINE Network is investigating the interactions between inflammation, microbiome, diet and mental health in patients with inflammatory.

Musculoskeletal Health in Europe

High and increasing prevalence of inflammatory bowel disease in Finland with a clear North–South difference Airi Jussila, Lauri J. Virta, Veikko Salomaa,

The Project – EuroHeart II

Medical management of inflammatory bowel disease

1 Patient enrollment flow chart.

Serum prohepcidin levels in chronic inflammatory bowel diseases

Figure 3. Proposed algorithm of treatment for patients with a diagnosis of PI [prepouch ileitis]. From: Prepouch Ileitis After Ileal Pouch-anal Anastomosis:

Clinical Correlates of Mental Health Issues in Outpatients with Inflammatory Bowel Disease under Routine Care Taryn Lores Health Psychologist, IBD Service.

Get Here is the best Treatment for Ulcerative Colitis

Age-related differences in presentation and course of inflammatory bowel disease: an update on the population-based literature Dana Duricova, Johan Burisch,

James E. Everhart, Constance E. Ruhl Gastroenterology

Volume 147, Issue 4, Pages e7 (October 2014)

Research and Healthcare in Inflammatory Bowel Diseases (1)

Osteoporosis in inflammatory bowel disease

Value Based Healthcare -A paradigm shift?

The International Consortium for Personalised Medicine

The issue of compliance

Respondent suggestions as to how best to protocol case selection for the inflammatory bowel disease (IBD) multidisciplinary team (MDT)—application of an.

Eligibility criteria for inclusion as an expert Delphi panellist

Component 1: Introduction to Health Care and Public Health in the U.S.

Rectal Mucosal Nitric Oxide in Differentiation of Inflammatory Bowel Disease and Irritable Bowel Syndrome Claudia I. Reinders, Max Herulf, Tryggve Ljung,

Base: Adults with any chronic condition

EESC Public Hearing 30-Jan-2019

David S. Fefferman, Richard J. Farrell

Respondent suggestions as to how best to protocol case selection for the inflammatory bowel disease (IBD) multidisciplinary team (MDT)—application of an.

Base: Adults with any chronic condition

Risk factors for postoperative infection after lower gastrointestinal surgery in patients with inflammatory bowel disease: Findings from a large epidemiological.

Cox regression analysis of the proportion of patients remaining in remission during azathioprine treatment related to diagnosis of inflammatory bowel disease.

Cox regression analysis of the proportion of patients remaining in remission after stopping azathioprine treatment related to diagnosis of inflammatory.

Presentation transcript:

Health Care and Research Simon Travis, Oxford UK, President of ECCO, EFCCA meeting E Parliament, 17 October 2013

ECCO Educational Workshops – where we have been so far…

Cooperation between ECCO and its partners Guidelines 2013/2014: ESGAR – Imaging ESP – Histopathology ESPGHAN – Paediatrics (UC & CD) ESCP – Surgery (UC) ECCO-EFCCA Join the Fight! Research EHFG ECCO-UEG cooperation (EMA) Concept paper on the revision of the guideline on the development of medicinal products for the treatment of Ulcerative Colitis (CHMP/EWP/18463/2006) ESGE Symposium Quality in Endoscopy: IBD & Small Bowel Disease Budapest, Nov. 15-16, 2013 AOCC Inaugural meeting Jun 14-15 ECCO@WCOG Symposium on colorectal disease Shanghai, Sep 21-24, 2013 ECCO-CIMF Summer School Guangzhou, China, April 25-28, 2013 ECCO Partners

Health care & Research IBD Lifelong diseases 3m in the EU, >€5bn/y direct healthcare costs National & regional disparities in diagnosis, access, disability 2013 survey of 5003 patients from 6 countries >25% waited >1y for diagnosis unchanged over 20y SpNurse access 8% FR, 52% UK Patient association info 21% SP, 39% UK Variation in multidisciplinary teams Change is achievable Differences in medical care affect HC utilisation ED visits etc) Burisch et al J Crohns Colitis 2013: Burden of IBD in Europe Lakatos et al J Crohns Colitis 2014: Disparities in IBD care in Europe

Health care & Research Research Learn from cardiologists: investigate what PRECEDES disease Focus on the microbiome Explore the environment through the exposome QoL Patients are part of the solution Real time data collection for a fluctuating condition Manage the manageable EC Health Strategy 2014-2020 ‘Chronic disease’ to include inflammatory disease Respond to economics: reduce expensive emergencies Involve patients: facilitate web-based models of care Organisation of care > expensive drugs for a minority